Combination of Atezolizumab and Pirfenidone in Second-line and Beyond NSCLC
Clinical trial NCT04467723 · RECRUITING
Trial details
- NCT number
- NCT04467723
- Sponsor
- University of Kansas Medical Center
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-18
- Primary completion
- 2027-01-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.